iBio (IBIO) Receivables (2011 - 2025)

iBio (IBIO) has 14 years of Receivables data on file, last reported at $65000.0 in Q3 2025.

• On a quarterly basis, Receivables changed N/A year-over-year to $65000.0 in Q3 2025; TTM through Sep 2025 was $65000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $204000.0, down 96.66% from the prior year.
• Receivables for Q3 2025 stood at $65000.0, down from $5.2 million in the prior quarter.
• Over the last five years, Receivables for IBIO reached as high as $10.6 million in Q2 2021 and fell as low as $65000.0 in Q3 2025.
• Historically, Receivables has averaged $4.6 million across 4 years, with a median of $5.3 million in 2021.
• Across the five-year window, Receivables soared 2146.12% in 2021 and plunged 90.59% in 2022, its largest moves.
• Year by year, Receivables stood at $5.2 million in 2021, then rose by 16.48% to $6.1 million in 2022, then fell by 14.83% to $5.2 million in 2023, then slumped by 98.74% to $65000.0 in 2025.
• Per Business Quant data, the three most recent Receivables figures were $65000.0 in Q3 2025, $5.2 million in Q1 2023, and $6.1 million in Q4 2022.